ロード中...
Risk stratification of patients with atrial fibrillation: Biomarkers and other future perspectives
Risk stratification of atrial fibrillation (AF) and adequate thromboembolism prophylaxis is the cornerstone of treatment in patients with AF. Current risk stratification schemes such as the CHADS(2) and CHA(2)DS(2)-VASc scores are based on clinical risk factors and suboptimally weight the risk/benef...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Baishideng Publishing Group Co., Limited
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3386309/ https://ncbi.nlm.nih.gov/pubmed/22761972 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4330/wjc.v4.i6.195 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|